Viridian Therapeutics, Inc.\DE (VRDN) Enterprise Value (2014 - 2026)
Viridian Therapeutics, Inc.\DE's Enterprise Value was $1.1 billion in Q2 2026, up 90.0% from $578.13 million a year earlier but down 11.5% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Enterprise Value (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Viridian Therapeutics, Inc.\DE's Enterprise Value was -$1.03 billion through Jun 30, 2026; for FY2025, it came in at $1.76 billion, up 111.3% from FY2024.
- In earlier years, Enterprise Value was $835.07 million in FY2024 (+67.9%), $497.4 million in FY2023 (-3.0%), $512.72 million in FY2022 and $38.67 million in FY2021.
- Quarterly Enterprise Value has moved between -$29.84 million (Q3 2021) and $1.76 billion (Q4 2025) over five years.
- Compared with a year earlier, Enterprise Value has increased for five straight quarters, with growth averaging 96.0% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q2 2023 (growth of 317.6%); the worst was Q2 2024 (a decline of 63.0%).
- Per Business Quant data, VRDN's Enterprise Value in the three quarters before Q2 2026 was $1.24 billion (Q1 2026), $1.76 billion (Q4 2025) and $1.28 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.36 Bn | -752.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Bn |
| Mar 31, 2026 | 1.24 Bn |
| Dec 31, 2025 | 1.76 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 578.13 Mn |
| Mar 31, 2025 | 463.19 Mn |
| Dec 31, 2024 | 835.07 Mn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 259.71 Mn |
| Mar 31, 2024 | 503.93 Mn |
| Dec 31, 2023 | 497.40 Mn |
| Sep 30, 2023 | 357.37 Mn |
| Jun 30, 2023 | 702.05 Mn |
| Mar 31, 2023 | 721.47 Mn |
| Dec 31, 2022 | 512.72 Mn |
| Sep 30, 2022 | 394.09 Mn |
| Jun 30, 2022 | 168.12 Mn |
| Mar 31, 2022 | 266.93 Mn |
| Dec 31, 2021 | 38.67 Mn |
| Sep 30, 2021 | -29.84 Mn |
API Access
Viridian Therapeutics, Inc.\DE Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();